BillionToOne, Inc.

BLLN·NasdaqGS·Healthcare
Compare
113.89+3.44 (+3.11%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close110.45
Open113.86
Day range110.19114.91
52-week range61.96150.44
Off day high−0.89%
Off 52-week high−24.30%
Volume581.93K
Avg. volume (3M)646.46K
Market cap5.37B
EPS (TTM)0.6300
Forward P/E76.69
P/E ratio (TTM)180.78
Dividend yield—
Beta (5Y)—
Shares outstanding42.64M
Short interest11.22% of float
Earnings dateNov 4, 2026
Analyst target129.00
Profit margin8.35%

Against its peers

Compare in full ›
BLLN NEO MYGN PSNL RVTY NTRA
Market cap 5.37B 2.22B 575.81M 1.69B 17.79B 56.36B
P/E (TTM) 180.8 — — — 70.9 —
Forward P/E 76.7 54.5 -10.2 -16.3 26.9 -2,198.8
Price/book 9.9 2.8 1.9 6.2 2.5 30.8
Dividend yield — — — — 0.18% —
1-year change +1.39% +61.36% −8.21% +105.61% +76.60% +94.39%
Today +3.11% +1.90% −0.33% +0.25% −2.48% +0.62%

The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.

Latest news

All BLLN news ›
markets.businessinsider.com··2 outletsPositive

BillionToOne to Participate in Two Upcoming Investor Conferences

A live and archived webcast of the events will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/. BillionToOne to Participate in Two Upcoming Investor Conferences MENLO…

More from 1 other outlet
markets.businessinsider.com·Positive

BillionToOne announces the launch of Northstar Origin

BillionToOne (BLLN) announced the launch of Northstar Origin, a new liquid biopsy add-on test for tissue-of-origin prediction, along with the ex... BillionToOne announces the launch of Northstar Origin BillionToOne (BLLN) announced the…

Stock Titan·

BillionToOne CEO exercises options, sells shares

BillionToOne, Inc. (NASDAQ: BLLN) is a Menlo Park-based molecular diagnostics company using its QCT platform for prenatal and oncology genetic testing. BillionToOne CEO exercises options, sells shares The chairman and CEO's transactions…

Stock Titan·Positive

BillionToOne counsel exercises options on 2,000 shares

CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer FreightCar America, Inc. Updates Full-Year 2026 Outlook and Reports Preliminary Third Quarter 2026 Results Tradeweb to Acquire Trumid, Expanding Tradeweb’s Credit Capabilities…

Defense World·Positive

Billiontoone (NASDAQ:BLLN) CEO Sells $516,184.50 in Stock

Oguzhan Atay also recently made the following trade(s): Check Out Our Latest Stock Analysis on Billiontoone BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more…

From the 4Search news index, newest first.

In the news

35mentions in 30 days
35with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 35 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance